SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-19-042020
Filing Date
2019-11-08
Accepted
2019-11-08 08:02:08
Documents
59
Period of Report
2019-09-30

Document Format Files

Seq Description Document Type Size
1 10Q_Q3_2019 arna-10q_20190930.htm   iXBRL 10-Q 2601173
2 EX-31.1 arna-ex311_6.htm EX-31.1 15034
3 EX-31.2 arna-ex312_10.htm EX-31.2 15414
4 EX-32.1 arna-ex321_7.htm EX-32.1 8801
  Complete submission text file 0001564590-19-042020.txt   8474257

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA arna-20190930.xsd EX-101.SCH 45407
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE arna-20190930_cal.xml EX-101.CAL 64676
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE arna-20190930_def.xml EX-101.DEF 156470
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE arna-20190930_lab.xml EX-101.LAB 387927
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE arna-20190930_pre.xml EX-101.PRE 279271
61 EXTRACTED XBRL INSTANCE DOCUMENT arna-10q_20190930_htm.xml XML 1739444
Mailing Address 6154 NANCY RIDGE DRIVE SAN DIEGO CA 92121
Business Address 6154 NANCY RIDGE DRIVE SAN DIEGO CA 92121 858-453-7200
ARENA PHARMACEUTICALS INC (Filer) CIK: 0001080709 (see all company filings)

IRS No.: 232908305 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-31161 | Film No.: 191202143
SIC: 2834 Pharmaceutical Preparations